Marshall Wace North America L.P. - INSMED INC ownership

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of INSMED INC
ValueSharesWeighting
Q3 2020$533,000
+133.8%
16,617
+74.2%
0.00%
+200.0%
Q4 2019$228,000
-66.6%
9,539
-75.4%
0.00%
-75.0%
Q3 2019$683,000
+98.5%
38,715
+75.6%
0.00%
-63.6%
Q3 2013$344,00022,0430.01%
Other shareholders
INSMED INC shareholders Q4 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 5,889,491$148,709,64814.07%
Deep Track Capital, LP 6,000,000$151,500,0005.85%
Octagon Capital Advisors LP 1,284,000$32,421,0004.98%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,446,334$87,019,9344.70%
MPM BioImpact LLC 527,458$13,318,3153.56%
Novo Holdings A/S 1,339,304$33,817,4262.50%
Bleichroeder LP 325,000$8,206,2502.02%
GREAT POINT PARTNERS LLC 394,872$9,970,5181.82%
Endurant Capital Management LP 79,471$2,006,6431.80%
SECTORAL ASSET MANAGEMENT INC 347,392$8,771,6481.71%
View complete list of INSMED INC shareholders